胃部・胃食道接合部腺癌:世界の薬剤市場予測・分析...市場調査レポートについてご紹介

【英文タイトル】PharmaPoint: Gastric and Gastroesophageal Junction Adenocarcinoma - Global Drug Forecast and Market Analysis to 2024

▼当市場調査レポートの詳細内容確認、お問い合わせ及びご購入申込は下記ページでお願いします。▼マーケットレポート

【レポートの概要(一部)】

1 Table of Contents
1 Table of Contents 10
1.1 List of Tables 17
1.2 List of Figures 23
2 Introduction 26
2.1 Catalyst 26
2.2 Related Reports 27
2.3 Upcoming Related Reports 27
3 Disease Overview 28
3.1 Etiology and Pathophysiology 28
3.1.1 Etiology 28
3.1.2 Pathophysiology 28
3.1.3 Biomarkers/Targets of Interest 30
3.2 Staging 31
3.3 Symptoms 33
3.4 Prognosis 33
3.5 Quality of Life 34
4 Epidemiology 36
4.1 Disease Background 36
4.2 Risk Factors and Comorbidities 37
4.3 Global Trends 38
4.3.1 8MM, Incidence Trends 39
4.4 Forecast Methodology 41
4.4.1 Sources Used 47
4.4.2 Sources Not Used 55
4.4.3 Forecast Assumptions and Methods, Diagnosed Incident Cases of Gastric Cancer – 8MM 56
4.4.4 Forecast Assumptions and Methods, Five-Year Diagnosed Prevalent Cases of Gastric Cancer – 8MM 57
4.4.5 Forecast Assumptions and Methods, Gastric Cancer Clinical Stages at Diagnosis – 8MM 58
4.4.6 Forecast Assumptions and Methods, Gastric Cancer Cellular Types – 8MM 59
4.4.7 Forecast Assumptions and Methods, HER2 Status – 8MM 61
4.4.8 Forecast Assumptions and Methods, Diagnosed Incident Cases of GEJ Cancer – 8MM 62
4.4.9 Forecast Assumptions and Methods, Diagnosed Incident Cases of Gastric Adenocarcinomas – 8MM 64
4.5 Epidemiological Forecast of Gastric Cancer (2014-2024) 64
4.5.1 Diagnosed Incident Cases of Gastric Cancer 64
4.5.2 Age-Specific Diagnosed Incident Cases of Gastric Cancer 66
4.5.3 Sex-Specific Diagnosed Incident Cases of Gastric Cancer 67
4.5.4 Age-Standardized Diagnosed Incidence of Gastric Cancer 69
4.5.5 Percentage Distribution of Diagnosed Incident Cases of Gastric Cancer, by Stage at Diagnosis 70
4.5.6 Percentage Distribution of Diagnosed Incident Cases of Gastric Cancer, by Cellular Type 71
4.5.7 Diagnosed Incident Cases of Gastric Cancer by HER2 Status 72
4.5.8 Diagnosed Incident Cases of GEJ Cancer 74
4.5.9 Five-Year Diagnosed Prevalent Cases of Gastric Cancer 76
4.6 Discussion 77
4.6.1 Epidemiological Forecast Insight 77
4.6.2 Limitations of the Analysis 78
4.6.3 Strengths of the Analysis 79
5 Disease Management 80
5.1 Diagnosis and Treatment Overview 80
5.1.1 Screening 80
5.1.2 Diagnosis 81
5.1.3 Treatment Guidelines and Leading Prescribed Drugs 85
5.1.4 Clinical Practice 85
5.2 US 96
5.2.1 Screening and Diagnosis 97
5.2.2 Clinical Practice 97
5.3 France 99
5.3.1 Screening and Diagnosis 100
5.3.2 Clinical Practice 101
5.4 Germany 101
5.4.1 Screening and Diagnosis 102
5.4.2 Clinical Practice 103
5.5 Italy 104
5.5.1 Screening and Diagnosis 105
5.5.2 Clinical Practice 105
5.6 Spain 106
5.6.1 Screening and Diagnosis 107
5.6.2 Clinical Practice 107
5.7 UK 108
5.7.1 Screening and Diagnosis 109
5.7.2 Clinical Practice 109
5.8 Japan 110
5.8.1 Screening and Diagnosis 111
5.8.2 Clinical Practice 113
5.9 China 118
5.9.1 Screening and Diagnosis 119
5.9.2 Clinical Practice 120
6 Competitive Assessment 125
6.1 Overview 125
6.2 HER2-Targeted Therapy 126
6.2.1 Herceptin (trastuzumab) 126
6.3 Angiogenesis Inhibitors 137
6.3.1 Cyramza (ramucirumab) 137
6.3.2 Aitan (apatinib) 149
6.4 Chemotherapies 155
6.4.1 TS-1 (tegafur, gimeracil, oteracil) 155
6.4.2 Abraxane (nab-paclitaxel) 166
7 Unmet Need and Opportunity 173
7.1 Overview 173
7.2 First-Line Therapy for HER2-Negative Patients 174
7.2.1 Unmet Need 174
7.2.2 Gap Analysis 175
7.2.3 Opportunity 176
7.3 New Molecular Targets for Targeted Therapies 176
7.3.1 Unmet Need 176
7.3.2 Gap Analysis 177
7.3.3 Opportunity 178
7.4 Effective Perioperative and Postoperative Therapies 181
7.4.1 Unmet Need 181
7.4.2 Gap Analysis 182
7.4.3 Opportunity 183
7.5 More Efficacious HER2-Targeted Therapies 184
7.5.1 Unmet Need 184
7.5.2 Gap Analysis 185
7.5.3 Opportunity 186
7.6 Peritoneal Metastases 187
7.6.1 Unmet Need 187
7.6.2 Gap Analysis 188
7.6.3 Opportunity 189
7.7 Better Clinical Trial Design 190
7.7.1 Unmet Need 190
7.7.2 Gap Analysis 190
7.7.3 Opportunity 191
7.8 Early Detection of Gastric and Gastroesophageal Adenocarcinomas 193
7.8.1 Unmet Need 193
7.8.2 Gap Analysis 194
7.8.3 Opportunity 195
8 Pipeline Assessment 196
8.1 Overview 196
8.2 Promising Drugs in Phase III Clinical Development 197
8.3 HER2-Targeted Therapies 198
8.3.1 Kadcyla (T-DM1; trastuzumab emtansine) 198
8.3.2 Perjeta (pertuzumab) 203
8.4 Immune Checkpoint Inhibitors 211
8.4.1 Keytruda (pembrolizumab) 211
8.4.2 Opdivo (nivolumab) 218
8.5 Further Strategies for G/GEJAC Treatment 224
8.5.1 Napabucasin 224
8.5.2 Lynparza (olaparib) 231
8.5.3 Nimotuzumab 239
8.5.4 TAS-118 247
8.6 Early/Near-Phase III Pipeline Drugs 252
8.6.1 GS-5745 252
8.6.2 Masitinib 256
8.7 Promising Drugs in Early-Stage Development 261
8.7.1 Immune Checkpoint Inhibitors 261
8.7.2 MET-Targeting Drugs 263
8.7.3 Antibody-Drug Conjugates 265
8.8 Biosimilars 269
9 Current and Future Players 272
9.1 Overview 272
9.2 Trends in Corporate Strategy 275
9.3 Company Profiles 276
9.3.1 Bristol-Myers Squibb 276
9.3.2 Eli Lilly and Company 279
9.3.3 Merck & Co. 282
9.3.4 Roche 285
9.3.5 Taiho Pharmaceutical 289
9.3.6 Sumitomo Dainippon Pharma 291
10 Market Outlook 294
10.1 Global Markets 294
10.1.1 Forecast 294
10.1.2 Drivers and Barriers – Global Issues 298
10.2 US 301
10.2.1 Forecast 301
10.2.2 Key Events 305
10.2.3 Drivers and Barriers – US 305
10.3 5EU 308
10.3.1 Forecast 308
10.3.2 Key Events 312
10.3.3 Drivers and Barriers – France 312
10.3.4 Drivers and Barriers – Germany 315
10.3.5 Drivers and Barriers – Italy 317
10.3.6 Drivers and Barriers – Spain 319
10.3.7 Drivers and Barriers – UK 321
10.4 Japan 324
10.4.1 Forecast 324
10.4.2 Key Events 328
10.4.3 Drivers and Barriers – Japan 328
10.5 China 331
10.5.1 Forecast 331
10.5.2 Key Events 335
10.5.3 Drivers and Barriers – China 335
11 Appendix 339
11.1 Bibliography 339
11.2 Abbreviations 374
11.3 Methodology 382
11.4 Forecasting Methodology 382
11.4.1 Diagnosed G/GEJAC Patients 382
11.4.2 Percent of Drug-Treated Patients 383
11.4.3 Drugs Included in Each Therapeutic Class 383
11.4.4 Launch and Patent Expiry Dates 384
11.4.5 General Pricing Assumptions 385
11.4.6 Individual Drug Assumptions 387
11.4.7 Generic Erosion 400
11.4.8 Pricing of Pipeline Agents 400
11.5 Primary Research – Key Opinion Leaders Interviewed for this Report 402
11.6 Primary Research – High-Prescriber Survey 405
11.7 About the Authors 406
11.7.1 Analyst 406
11.7.2 Therapy Area Director 406
11.7.3 Epidemiologist 407
11.7.4 Global Head of Healthcare 407
11.8 About GlobalData 408
11.9 Disclaimer 408


【レポート販売概要】

■ タイトル:胃部・胃食道接合部腺癌:世界の薬剤市場予測・分析
■ 英文:PharmaPoint: Gastric and Gastroesophageal Junction Adenocarcinoma - Global Drug Forecast and Market Analysis to 2024
■ 発行日:2015年12月
■ 調査会社:GlobalData
■ 商品コード:GDHC123PIDR
■ 調査対象地域:グローバル
  • ライスケーキの世界市場2018-2022
    98 pages, November 2018 About this market In recent times, the rice cakes market has witnessed a staggering number of new products introduced to the market by many regional and international players which is significantly supporting the growth of the rice cakes market worldwide. Indeed, manufacturers of rice-based snacks are launching a wide range of products with a blend of unique ingredients whi …
  • 口腔がん治療法の世界市場2019-2023
    Global Oral Cancer Therapeutics Market: About this market Technavio’s oral cancer therapeutics market analysis considers sales from both targeted therapy and chemotherapy. Our analysis also considers the sales of oral cancer therapeutics in Asia, Europe, North America, and ROW. In 2018, the targeted therapy segment had a significant market share, and this trend is expected to continue over the for …
  • 子供向け間食(おやつ)市場
    Summary 'The Children's Snacking Market: key trends and future developments shaping the market' is a detailed consumer insight report, exploring into the future of Kids Snacking in both developing and developed countries. It examines market growth, consumer behavior, and product development by leading innovators in order to highlight the most important trends and identify untapped opportunities. K …
  • 世界のナイフ/包丁市場(~2019):主要10か国
    This industry report package offers the most up-to-date market data on the actual market situation, trends, and future outlook for knives in the world and in the top 10 global countries. Along with a global knife market report the package includes country reports from the following countries: Canada, China, France, Germany, Italy, Japan, Netherlands, Spain, United Kingdom, United States The report …
  • ケアマネジメントソリューションの世界市場予測(~2021)
    The care management solutions market is projected to reach USD 15.70 Billion by 2021 from USD 6.93 Billion in 2016, growing at a CAGR of 17.8%. Factors such as the implementation of initiatives to shift the burden of risk from payers to providers, legislations and initiatives to promote ‘patient-centeredness’ in healthcare, rising geriatric population coupled with the burden of chronic diseases, n …
  • 金属構造物製造装置の世界市場:金属切断装置、金属成形装置、金属溶接装置
    About Metal Fabrication Metal fabrication is a process that involves building metal structures by cutting, bending, and assembling. Metal fabrication is a value-added process that encompasses the construction of machines and other structures from various raw materials. Large fabrication shops may employ a range of value-added processes that include welding, cutting, forming, and machining in a sin …
  • 感染予防の世界市場予測(~2021年):消毒剤、消毒器、内視鏡洗浄機、洗浄綿、フェイスマスク、蒸気滅菌、エチレンオキシド、VHP、Eビーム、契約消毒サービス
    The global infection control market is expected to reach USD 17.78 Billion by 2021 from USD 13.00 Billion in 2016, at a CAGR of 6.5% during the forecast period of 2016 to 2021. Rising incidence of hospital acquired infections (HAIs), growth in the number of surgical procedures, growing aging population, and rising focus on the need of food sterilization and disinfection are major factors driving t …
  • 自動車AR(拡張現実)の世界市場2016-2020
    About the Automotive Augmented Reality Market Need for AR: Deficits of existing HUDs HUDs have been around since the late 1980s, when General Motors (GM) used it in their Oldsmobile. However, the principal reason for having HUDs, which is to reduce the need of the driver to look away from the road, never changed. Primary deficiencies of conventional HUDs • Irrelevant information and on-screen spac …
  • 自動車用調整可能ステアリングシステムの世界市場:手動調整可能ステアリング、電気的調整可能ステアリング
    Global Automotive Adjustable Steering System Market: About this market An automotive adjustable steering system improves the safety and comfort of the driver. Technavio’s automotive adjustable steering system market analysis considers sales from the manually adjustable steering and electrically adjustable steering segments. Our analysis also considers the sales of automotive adjustable steering sy …
  • 世界のリアルタイム位置情報システム(RTLS)市場動向及び予測(2013~2018)
    Real-Time Location Systems facilitate real-time tracking of assets and personnel in indoor as well as outdoor environments, with the use of active RFID tags which employ wireless technologies such as RF signals, Wi-Fi, UWB, ultrasound, Infrared, and Zigbee for communication with location readers/sensors. With RTLS, enterprises now have this opportunity to track and manage their resources for enhan …
  • グローバルにおける電力ケーブル市場(2014-2018)
    About Power Cables A power cable is an insulated strand of wires that is used to transmit electricity at variable voltage levels. Power cables are mainly used in overhead lines, buildings, and underground wiring applications to transmit electricity. Power cables are available in different sizes and shapes according to the requirements of the Telecommunication, Electrical Equipment, Construction, a …
  • エピジェネティクスの世界市場:修飾酵素、DNAポリメラーゼ、アセチラーゼ、メチルトランスフェラーゼ、機器、消耗品、キット、試薬
    The epigenetics market is expected to reach USD 890.0 Million by 2020 from USD 469.6 Million in 2015, at a CAGR of 13.64% between 2015 and 2020. Increasing research activities by academic and research institutes and high prevalence of cancer will majorly drive the growth of the market. Other growth factors include the increasing application for non-oncology diseases; and growing partnership betwee …
  • 世界の拡張現実(AR)市場動向(2012-2016)
    TechNavio's analysts forecast the Global Augmented Reality market to grow at a CAGR of 54.3 percent over the period 2012-2016. One of the key factors contributing to this market growth is the increasing demand for enhanced user experience. The Global Augmented Reality market has also been witnessing increasing partnerships or tie-ups between startups of this market and major players in the complem …
  • 世界のインターネット広告市場:ペイド・サーチ(検索連動型広告)、ディスプレイ広告、クラシファイド広告
    About Internet Advertising Online advertising is a medium which uses internet for advertising a product or services. It is one of the most popular media of advertising because of its wide reach, flexibility, and accessibility. One of the benefits of internet advertising is that it can be customized, making consumer targeting more efficient and precise. For instance, Yahoo search, AdWords, and Goog …
  • コンビネーションスタータの世界市場
    Global combination starter market is projected to grow at a CAGR of 5.19% from 2015 to 2020, to reach a market size of USD 926.6 Million by 2020. This growth can be attributed to the increasing demand for motors and growing concerns related to motor control & protection. All equipment and services related to electricity, power transmission, and electronics require motor control and protection, alo …
※当サイトは世界の市場調査レポート紹介サイトです。市場規模、市場動向、市場予測など、多様な分析データを含むグローバル調査レポートをご案内致します。日本国内を含むアジア太平洋、中国、ヨーロッパ、アメリカ、北米、中南米、中東、アフリカ地域などにおける、製品、サービス、技術、企業(メーカー、ベンダー)、市場シェア、市場環境など多様な項目に対応致します。当サイトでご紹介するレポートは「市場調査レポート販売サイトのMarketReport.jp」でお問い合わせ及びご購入可能です。